CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphoma.
作者信息
Gandhi Maher K, Keane Colm
机构信息
Mater Research, University of Queensland, Brisbane, Queensland; Haematology Dept., Princess Alexandra Hospital, Brisbane, Queensland.
Haematology Dept., Princess Alexandra Hospital, Brisbane, Queensland; University of Queensland Diamantina Institute, Brisbane, Queensland.
出版信息
Haematologica. 2023 Apr 1;108(4):945-946. doi: 10.3324/haematol.2022.281440.
Abstract
摘要
相似文献
1
CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphoma.CD4 T细胞：开启经典型霍奇金淋巴瘤免疫微环境的复杂关键因素
Haematologica. 2023 Apr 1;108(4):945-946. doi: 10.3324/haematol.2022.281440.
2
Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma.梭形 CD163+ 玫瑰花结形成的巨噬细胞取代 HIV 相关经典霍奇金淋巴瘤中的 CD4+ T 细胞。
Mod Pathol. 2013 May;26(5):648-57. doi: 10.1038/modpathol.2012.217. Epub 2013 Jan 11.
3
The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma.微环境在人类免疫缺陷病毒相关性经典霍奇金淋巴瘤中的作用。
Histopathology. 2014 Dec;65(6):749-56. doi: 10.1111/his.12458. Epub 2014 Oct 28.
4
A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.双阳性CD4⁺CD8⁺ T细胞群体常见于结节性淋巴细胞为主型霍奇金淋巴瘤。
Am J Clin Pathol. 2006 Nov;126(5):805-14. doi: 10.1309/Y8KD-32QG-RYFN-1XQX.
5
Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma.检测调节性T细胞在经典型霍奇金淋巴瘤的诊断中具有潜在作用。
Cytometry B Clin Cytom. 2008 Jul;74(4):227-35. doi: 10.1002/cyto.b.20407.
6
CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.发生霍奇金淋巴瘤或非霍奇金淋巴瘤的无病毒血症HIV感染患者的CD4 +和CD8 + T细胞动力学
AIDS. 2016 Mar 13;30(5):753-60. doi: 10.1097/QAD.0000000000000980.
7
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).B细胞非霍奇金淋巴瘤（NHL）或霍奇金病（HD）侵袭的肿瘤中CD4 T淋巴细胞的CD45RA表达。
Am J Hematol. 1992 Jan;39(1):45-51. doi: 10.1002/ajh.2830390110.
8
Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.经典型霍奇金淋巴瘤中程序性死亡-1+肿瘤浸润淋巴细胞增加，证实总生存期缩短。
Hum Pathol. 2009 Dec;40(12):1715-22. doi: 10.1016/j.humpath.2009.03.025. Epub 2009 Aug 19.
9
Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes.CD7在经典型霍奇金淋巴瘤浸润性T淋巴细胞中的过表达。
Cytometry B Clin Cytom. 2009 May;76(3):169-74. doi: 10.1002/cyto.b.20459.
10
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.经典型霍奇金淋巴瘤中B细胞标志物的表达：330例组织芯片分析
Mod Pathol. 2003 Nov;16(11):1141-7. doi: 10.1097/01.MP.0000093627.51090.3F.
引用本文的文献
1
T cells in cancer: mechanistic insights and therapeutic advances.癌症中的T细胞：机制洞察与治疗进展
Biomark Res. 2025 Jul 15;13(1):97. doi: 10.1186/s40364-025-00807-w.
本文引用的文献
1
PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion.PDL1 塑造经典霍奇金淋巴瘤微环境而不诱导 T 细胞耗竭。
Haematologica. 2023 Apr 1;108(4):1068-1082. doi: 10.3324/haematol.2022.280014.
2
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma.抗 PD-1 一线治疗霍奇金淋巴瘤中循环淋巴细胞衰竭表型逆转作为免疫相关性标志物。
Leukemia. 2022 Mar;36(3):760-771. doi: 10.1038/s41375-021-01421-z. Epub 2021 Sep 28.
3
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.卡米丹单抗 tesirine 治疗复发或难治性淋巴瘤患者的 1 期、开放标签、多中心、剂量递增、剂量扩展研究。
Lancet Haematol. 2021 Jun;8(6):e433-e445. doi: 10.1016/S2352-3026(21)00103-4.
4
The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.CD4+ T 细胞在 PD-1 阻断针对 MHC-II 表达肿瘤（如经典霍奇金淋巴瘤）中的关键作用。
Blood Adv. 2020 Sep 8;4(17):4069-4082. doi: 10.1182/bloodadvances.2020002098.
5
A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma.经典型霍奇金淋巴瘤患者对 PD-1 阻断治疗反应的外周免疫特征。
Nat Med. 2020 Sep;26(9):1468-1479. doi: 10.1038/s41591-020-1006-1. Epub 2020 Aug 10.
6
Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.单细胞转录组分析揭示经典霍奇金淋巴瘤肿瘤微环境中的疾病定义性 T 细胞亚群。
Cancer Discov. 2020 Mar;10(3):406-421. doi: 10.1158/2159-8290.CD-19-0680. Epub 2019 Dec 19.
7
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma.PD-L1 介导的反向信号促进经典型霍奇金淋巴瘤中恶性细胞的生长和存活。
Blood Cancer J. 2019 Feb 19;9(3):22. doi: 10.1038/s41408-019-0185-9.
8
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.纳武利尤单抗治疗自体造血干细胞移植后复发/难治性经典型霍奇金淋巴瘤：CheckMate 205 试验多队列单臂 2 期研究的随访扩展。
J Clin Oncol. 2018 May 10;36(14):1428-1439. doi: 10.1200/JCO.2017.76.0793. Epub 2018 Mar 27.
9
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.NK 细胞和单核细胞/巨噬细胞上的 PD-1/PD-L1 免疫逃逸在霍奇金淋巴瘤中比 DLBCL 更为显著。
Blood. 2018 Apr 19;131(16):1809-1819. doi: 10.1182/blood-2017-07-796342. Epub 2018 Feb 15.
10
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.拓扑分析揭示了霍奇金淋巴瘤中里德-施特恩伯格细胞的一种与程序性死亡配体1相关的微环境生态位。
Blood. 2017 Nov 30;130(22):2420-2430. doi: 10.1182/blood-2017-03-770719. Epub 2017 Sep 11.
Zotero 插件